Quarterly report pursuant to Section 13 or 15(d)

Combined Statements of Operations (Unaudited)

v3.20.2
Combined Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue, net $ 349,000   $ 349,000  
Operating expenses:        
Cost of sales 650,000   650,000  
Research and development 1,350,000 $ 7,180,000 4,420,000 $ 16,734,000
Selling, general and administrative 11,217,000 7,449,000 19,263,000 17,284,000
Amortization of intangible assets 644,000 0 859,000 0
Change in warrant valuation 12,667,000   14,045,000  
Change in contingent consideration valuation 4,053,000 (4,059,000) 31,679,000 (19,150,000)
Total operating expenses 30,581,000 10,570,000 70,916,000 14,868,000
Operating loss (30,232,000) (10,570,000) (70,567,000) (14,868,000)
Other expense:        
Other expense (213,000) (12,000) (176,000) (49,000)
Net loss $ (30,445,000) $ (10,582,000) $ (70,743,000) $ (14,917,000)
Per share information:        
Net loss per share of common stock, basic and diluted $ (1.72) $ (1.13) $ (5.11) $ (1.60)
Weighted average common shares outstanding, basic and diluted 17,691,700 9,350,709 13,846,464 9,350,709